Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:telehealth obesity monitoring'
(id=8858710 ; fe=en:telehealth obesity monitoring ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=6972 creation date=2017-09-04 touchdate=2024-11-20 05:37:26.000)
≈ 243 relations sortantes

  1. en:telehealth obesity monitoring -- r_associated #0: 41 / 1 -> en:circulatory care: arterial insufficiency
    n1=en:telehealth obesity monitoring | n2=en:circulatory care: arterial insufficiency | rel=r_associated | relid=0 | w=41
  2. en:telehealth obesity monitoring -- r_associated #0: 41 / 1 -> en:counseling about physical activity
    n1=en:telehealth obesity monitoring | n2=en:counseling about physical activity | rel=r_associated | relid=0 | w=41
  3. en:telehealth obesity monitoring -- r_associated #0: 38 / 0.927 -> en:assessment of ability to prepare food
    n1=en:telehealth obesity monitoring | n2=en:assessment of ability to prepare food | rel=r_associated | relid=0 | w=38
  4. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:allergy education
    n1=en:telehealth obesity monitoring | n2=en:allergy education | rel=r_associated | relid=0 | w=35
  5. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:amniotic fluid analysis for erythroblastosis fetalis
    n1=en:telehealth obesity monitoring | n2=en:amniotic fluid analysis for erythroblastosis fetalis | rel=r_associated | relid=0 | w=35
  6. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:anesthesia for abdominal wound dehiscence
    n1=en:telehealth obesity monitoring | n2=en:anesthesia for abdominal wound dehiscence | rel=r_associated | relid=0 | w=35
  7. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:assessment of diabetic erectile dysfunction
    n1=en:telehealth obesity monitoring | n2=en:assessment of diabetic erectile dysfunction | rel=r_associated | relid=0 | w=35
  8. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:assessment of dizziness
    n1=en:telehealth obesity monitoring | n2=en:assessment of dizziness | rel=r_associated | relid=0 | w=35
  9. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:assessment of hyperalgesia
    n1=en:telehealth obesity monitoring | n2=en:assessment of hyperalgesia | rel=r_associated | relid=0 | w=35
  10. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:assessment of psychological response to pain
    n1=en:telehealth obesity monitoring | n2=en:assessment of psychological response to pain | rel=r_associated | relid=0 | w=35
  11. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:counseling for infertility
    n1=en:telehealth obesity monitoring | n2=en:counseling for infertility | rel=r_associated | relid=0 | w=35
  12. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:counseling for menopause
    n1=en:telehealth obesity monitoring | n2=en:counseling for menopause | rel=r_associated | relid=0 | w=35
  13. en:telehealth obesity monitoring -- r_associated #0: 35 / 0.854 -> en:ct of trunk for assessment for solid organ injury
    n1=en:telehealth obesity monitoring | n2=en:ct of trunk for assessment for solid organ injury | rel=r_associated | relid=0 | w=35
  14. en:telehealth obesity monitoring -- r_associated #0: 34 / 0.829 -> en:adverse drug reaction prevention
    n1=en:telehealth obesity monitoring | n2=en:adverse drug reaction prevention | rel=r_associated | relid=0 | w=34
  15. en:telehealth obesity monitoring -- r_associated #0: 34 / 0.829 -> en:assessment of physiological status
    n1=en:telehealth obesity monitoring | n2=en:assessment of physiological status | rel=r_associated | relid=0 | w=34
  16. en:telehealth obesity monitoring -- r_associated #0: 34 / 0.829 -> en:assessment: respiration
    n1=en:telehealth obesity monitoring | n2=en:assessment: respiration | rel=r_associated | relid=0 | w=34
  17. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:allergy medication review
    n1=en:telehealth obesity monitoring | n2=en:allergy medication review | rel=r_associated | relid=0 | w=32
  18. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:anxiety counseling
    n1=en:telehealth obesity monitoring | n2=en:anxiety counseling | rel=r_associated | relid=0 | w=32
  19. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:assessment for risk of cancer
    n1=en:telehealth obesity monitoring | n2=en:assessment for risk of cancer | rel=r_associated | relid=0 | w=32
  20. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:assessment of dementia
    n1=en:telehealth obesity monitoring | n2=en:assessment of dementia | rel=r_associated | relid=0 | w=32
  21. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:assessment of risk for impaired nutritional status
    n1=en:telehealth obesity monitoring | n2=en:assessment of risk for impaired nutritional status | rel=r_associated | relid=0 | w=32
  22. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:atypical pneumonia screening test
    n1=en:telehealth obesity monitoring | n2=en:atypical pneumonia screening test | rel=r_associated | relid=0 | w=32
  23. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:cancer education
    n1=en:telehealth obesity monitoring | n2=en:cancer education | rel=r_associated | relid=0 | w=32
  24. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:contraceptive methods
    n1=en:telehealth obesity monitoring | n2=en:contraceptive methods | rel=r_associated | relid=0 | w=32
  25. en:telehealth obesity monitoring -- r_associated #0: 32 / 0.78 -> en:counseling about fear
    n1=en:telehealth obesity monitoring | n2=en:counseling about fear | rel=r_associated | relid=0 | w=32
  26. en:telehealth obesity monitoring -- r_associated #0: 31 / 0.756 -> en:alcohol consumption screening
    n1=en:telehealth obesity monitoring | n2=en:alcohol consumption screening | rel=r_associated | relid=0 | w=31
  27. en:telehealth obesity monitoring -- r_associated #0: 31 / 0.756 -> en:amniocentesis for possible chromosomal abnormality
    n1=en:telehealth obesity monitoring | n2=en:amniocentesis for possible chromosomal abnormality | rel=r_associated | relid=0 | w=31
  28. en:telehealth obesity monitoring -- r_associated #0: 31 / 0.756 -> en:assessment of raised intracranial pressure
    n1=en:telehealth obesity monitoring | n2=en:assessment of raised intracranial pressure | rel=r_associated | relid=0 | w=31
  29. en:telehealth obesity monitoring -- r_associated #0: 31 / 0.756 -> en:assessment of risk for dehydration
    n1=en:telehealth obesity monitoring | n2=en:assessment of risk for dehydration | rel=r_associated | relid=0 | w=31
  30. en:telehealth obesity monitoring -- r_associated #0: 31 / 0.756 -> en:assessment of self esteem
    n1=en:telehealth obesity monitoring | n2=en:assessment of self esteem | rel=r_associated | relid=0 | w=31
  31. en:telehealth obesity monitoring -- r_associated #0: 31 / 0.756 -> en:chemotherapy for non-malignant neoplasm
    n1=en:telehealth obesity monitoring | n2=en:chemotherapy for non-malignant neoplasm | rel=r_associated | relid=0 | w=31
  32. en:telehealth obesity monitoring -- r_associated #0: 31 / 0.756 -> en:counseling about diagnositic imaging findings
    n1=en:telehealth obesity monitoring | n2=en:counseling about diagnositic imaging findings | rel=r_associated | relid=0 | w=31
  33. en:telehealth obesity monitoring -- r_associated #0: 30 / 0.732 -> en:antenatal risk assessment
    n1=en:telehealth obesity monitoring | n2=en:antenatal risk assessment | rel=r_associated | relid=0 | w=30
  34. en:telehealth obesity monitoring -- r_associated #0: 30 / 0.732 -> en:arthritis medication review
    n1=en:telehealth obesity monitoring | n2=en:arthritis medication review | rel=r_associated | relid=0 | w=30
  35. en:telehealth obesity monitoring -- r_associated #0: 30 / 0.732 -> en:assessment of allodynia
    n1=en:telehealth obesity monitoring | n2=en:assessment of allodynia | rel=r_associated | relid=0 | w=30
  36. en:telehealth obesity monitoring -- r_associated #0: 30 / 0.732 -> en:assessment of fatigue
    n1=en:telehealth obesity monitoring | n2=en:assessment of fatigue | rel=r_associated | relid=0 | w=30
  37. en:telehealth obesity monitoring -- r_associated #0: 30 / 0.732 -> en:assessment of laser injury
    n1=en:telehealth obesity monitoring | n2=en:assessment of laser injury | rel=r_associated | relid=0 | w=30
  38. en:telehealth obesity monitoring -- r_associated #0: 30 / 0.732 -> en:chronic disease process education
    n1=en:telehealth obesity monitoring | n2=en:chronic disease process education | rel=r_associated | relid=0 | w=30
  39. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:activity of daily living procedures and interventions
    n1=en:telehealth obesity monitoring | n2=en:activity of daily living procedures and interventions | rel=r_associated | relid=0 | w=29
  40. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:anesthesia for pectus excavatum
    n1=en:telehealth obesity monitoring | n2=en:anesthesia for pectus excavatum | rel=r_associated | relid=0 | w=29
  41. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:assessment for risk of harm to others
    n1=en:telehealth obesity monitoring | n2=en:assessment for risk of harm to others | rel=r_associated | relid=0 | w=29
  42. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:assessment of appetite
    n1=en:telehealth obesity monitoring | n2=en:assessment of appetite | rel=r_associated | relid=0 | w=29
  43. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:assessment of risk for falls on admission
    n1=en:telehealth obesity monitoring | n2=en:assessment of risk for falls on admission | rel=r_associated | relid=0 | w=29
  44. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:asthma education
    n1=en:telehealth obesity monitoring | n2=en:asthma education | rel=r_associated | relid=0 | w=29
  45. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:cerebral edema management
    n1=en:telehealth obesity monitoring | n2=en:cerebral edema management | rel=r_associated | relid=0 | w=29
  46. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:clot retraction, screen
    n1=en:telehealth obesity monitoring | n2=en:clot retraction, screen | rel=r_associated | relid=0 | w=29
  47. en:telehealth obesity monitoring -- r_associated #0: 29 / 0.707 -> en:dementia management
    n1=en:telehealth obesity monitoring | n2=en:dementia management | rel=r_associated | relid=0 | w=29
  48. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:assessment of mood
    n1=en:telehealth obesity monitoring | n2=en:assessment of mood | rel=r_associated | relid=0 | w=28
  49. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:assessment of perioperative injury
    n1=en:telehealth obesity monitoring | n2=en:assessment of perioperative injury | rel=r_associated | relid=0 | w=28
  50. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:assessment of substance withdrawal
    n1=en:telehealth obesity monitoring | n2=en:assessment of substance withdrawal | rel=r_associated | relid=0 | w=28
  51. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:congenital hypothyroidism screening test
    n1=en:telehealth obesity monitoring | n2=en:congenital hypothyroidism screening test | rel=r_associated | relid=0 | w=28
  52. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:coronary heart disease education
    n1=en:telehealth obesity monitoring | n2=en:coronary heart disease education | rel=r_associated | relid=0 | w=28
  53. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:correction of trichiasis by epilation with forceps
    n1=en:telehealth obesity monitoring | n2=en:correction of trichiasis by epilation with forceps | rel=r_associated | relid=0 | w=28
  54. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:delirium management
    n1=en:telehealth obesity monitoring | n2=en:delirium management | rel=r_associated | relid=0 | w=28
  55. en:telehealth obesity monitoring -- r_associated #0: 28 / 0.683 -> en:dermatologic disorder medication review
    n1=en:telehealth obesity monitoring | n2=en:dermatologic disorder medication review | rel=r_associated | relid=0 | w=28
  56. en:telehealth obesity monitoring -- r_associated #0: 27 / 0.659 -> en:aspiration precautions
    n1=en:telehealth obesity monitoring | n2=en:aspiration precautions | rel=r_associated | relid=0 | w=27
  57. en:telehealth obesity monitoring -- r_associated #0: 27 / 0.659 -> en:assessment of breastfeeding
    n1=en:telehealth obesity monitoring | n2=en:assessment of breastfeeding | rel=r_associated | relid=0 | w=27
  58. en:telehealth obesity monitoring -- r_associated #0: 27 / 0.659 -> en:assessment of chest pain
    n1=en:telehealth obesity monitoring | n2=en:assessment of chest pain | rel=r_associated | relid=0 | w=27
  59. en:telehealth obesity monitoring -- r_associated #0: 27 / 0.659 -> en:assessment of risk for transfer injury
    n1=en:telehealth obesity monitoring | n2=en:assessment of risk for transfer injury | rel=r_associated | relid=0 | w=27
  60. en:telehealth obesity monitoring -- r_associated #0: 27 / 0.659 -> en:barium enema for radiological reduction of intussusception of ileum
    n1=en:telehealth obesity monitoring | n2=en:barium enema for radiological reduction of intussusception of ileum | rel=r_associated | relid=0 | w=27
  61. en:telehealth obesity monitoring -- r_associated #0: 27 / 0.659 -> en:bowel imaging for volvulus
    n1=en:telehealth obesity monitoring | n2=en:bowel imaging for volvulus | rel=r_associated | relid=0 | w=27
  62. en:telehealth obesity monitoring -- r_associated #0: 27 / 0.659 -> en:consultation for transition of care
    n1=en:telehealth obesity monitoring | n2=en:consultation for transition of care | rel=r_associated | relid=0 | w=27
  63. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:acid-base management: respiratory acidosis
    n1=en:telehealth obesity monitoring | n2=en:acid-base management: respiratory acidosis | rel=r_associated | relid=0 | w=26
  64. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:acid-base regulation: metabolic acidosis
    n1=en:telehealth obesity monitoring | n2=en:acid-base regulation: metabolic acidosis | rel=r_associated | relid=0 | w=26
  65. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:anesthesia for vaginal delivery
    n1=en:telehealth obesity monitoring | n2=en:anesthesia for vaginal delivery | rel=r_associated | relid=0 | w=26
  66. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:assessment of adverse drug reactions
    n1=en:telehealth obesity monitoring | n2=en:assessment of adverse drug reactions | rel=r_associated | relid=0 | w=26
  67. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:assessment of pregnancy status prior to imaging
    n1=en:telehealth obesity monitoring | n2=en:assessment of pregnancy status prior to imaging | rel=r_associated | relid=0 | w=26
  68. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:assessment of skin integrity
    n1=en:telehealth obesity monitoring | n2=en:assessment of skin integrity | rel=r_associated | relid=0 | w=26
  69. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:counseling about tobacco use
    n1=en:telehealth obesity monitoring | n2=en:counseling about tobacco use | rel=r_associated | relid=0 | w=26
  70. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:counseling for unwanted pregnancy
    n1=en:telehealth obesity monitoring | n2=en:counseling for unwanted pregnancy | rel=r_associated | relid=0 | w=26
  71. en:telehealth obesity monitoring -- r_associated #0: 26 / 0.634 -> en:crisis intervention
    n1=en:telehealth obesity monitoring | n2=en:crisis intervention | rel=r_associated | relid=0 | w=26
  72. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:administration of prescribed medications based on arterial blood gas results
    n1=en:telehealth obesity monitoring | n2=en:administration of prescribed medications based on arterial blood gas results | rel=r_associated | relid=0 | w=20
  73. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:administration of prophylactic agent after sexual exposure
    n1=en:telehealth obesity monitoring | n2=en:administration of prophylactic agent after sexual exposure | rel=r_associated | relid=0 | w=20
  74. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:alcohol brief intervention
    n1=en:telehealth obesity monitoring | n2=en:alcohol brief intervention | rel=r_associated | relid=0 | w=20
  75. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:allergy management
    n1=en:telehealth obesity monitoring | n2=en:allergy management | rel=r_associated | relid=0 | w=20
  76. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:allergy screening test
    n1=en:telehealth obesity monitoring | n2=en:allergy screening test | rel=r_associated | relid=0 | w=20
  77. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:amniocentesis for possible neural tube defect
    n1=en:telehealth obesity monitoring | n2=en:amniocentesis for possible neural tube defect | rel=r_associated | relid=0 | w=20
  78. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:amniotic fluid analysis for hemolytic disease of the newborn
    n1=en:telehealth obesity monitoring | n2=en:amniotic fluid analysis for hemolytic disease of the newborn | rel=r_associated | relid=0 | w=20
  79. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:assessment for risk of cardiovascular disease
    n1=en:telehealth obesity monitoring | n2=en:assessment for risk of cardiovascular disease | rel=r_associated | relid=0 | w=20
  80. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:assessment of body movement
    n1=en:telehealth obesity monitoring | n2=en:assessment of body movement | rel=r_associated | relid=0 | w=20
  81. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:assessment of lymphedema
    n1=en:telehealth obesity monitoring | n2=en:assessment of lymphedema | rel=r_associated | relid=0 | w=20
  82. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:assessment of need for interpreter
    n1=en:telehealth obesity monitoring | n2=en:assessment of need for interpreter | rel=r_associated | relid=0 | w=20
  83. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:assessment of pre-existing conditions that predispose to inadequate tissue perfusion
    n1=en:telehealth obesity monitoring | n2=en:assessment of pre-existing conditions that predispose to inadequate tissue perfusion | rel=r_associated | relid=0 | w=20
  84. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:assessment of substance use
    n1=en:telehealth obesity monitoring | n2=en:assessment of substance use | rel=r_associated | relid=0 | w=20
  85. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:carotid sinus massage test
    n1=en:telehealth obesity monitoring | n2=en:carotid sinus massage test | rel=r_associated | relid=0 | w=20
  86. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:child abuse prevention
    n1=en:telehealth obesity monitoring | n2=en:child abuse prevention | rel=r_associated | relid=0 | w=20
  87. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:circulatory care: venous insufficency
    n1=en:telehealth obesity monitoring | n2=en:circulatory care: venous insufficency | rel=r_associated | relid=0 | w=20
  88. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:conflict mediation
    n1=en:telehealth obesity monitoring | n2=en:conflict mediation | rel=r_associated | relid=0 | w=20
  89. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:constipation care
    n1=en:telehealth obesity monitoring | n2=en:constipation care | rel=r_associated | relid=0 | w=20
  90. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:counseling about disease
    n1=en:telehealth obesity monitoring | n2=en:counseling about disease | rel=r_associated | relid=0 | w=20
  91. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:counseling about spiritual distress
    n1=en:telehealth obesity monitoring | n2=en:counseling about spiritual distress | rel=r_associated | relid=0 | w=20
  92. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:counseling for alternatives to driving
    n1=en:telehealth obesity monitoring | n2=en:counseling for alternatives to driving | rel=r_associated | relid=0 | w=20
  93. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:counseling for risks of driving
    n1=en:telehealth obesity monitoring | n2=en:counseling for risks of driving | rel=r_associated | relid=0 | w=20
  94. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:crime victim counseling
    n1=en:telehealth obesity monitoring | n2=en:crime victim counseling | rel=r_associated | relid=0 | w=20
  95. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:depression management program
    n1=en:telehealth obesity monitoring | n2=en:depression management program | rel=r_associated | relid=0 | w=20
  96. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:determination of resuscitation status
    n1=en:telehealth obesity monitoring | n2=en:determination of resuscitation status | rel=r_associated | relid=0 | w=20
  97. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:developmental enhancement: child
    n1=en:telehealth obesity monitoring | n2=en:developmental enhancement: child | rel=r_associated | relid=0 | w=20
  98. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:diabetic erectile dysfunction review
    n1=en:telehealth obesity monitoring | n2=en:diabetic erectile dysfunction review | rel=r_associated | relid=0 | w=20
  99. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:diarrhea care
    n1=en:telehealth obesity monitoring | n2=en:diarrhea care | rel=r_associated | relid=0 | w=20
  100. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:discussion about vaginal bleeding
    n1=en:telehealth obesity monitoring | n2=en:discussion about vaginal bleeding | rel=r_associated | relid=0 | w=20
  101. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of cardiovascular disorder medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of cardiovascular disorder medication action plan | rel=r_associated | relid=0 | w=20
  102. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of endocrine disorder medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of endocrine disorder medication action plan | rel=r_associated | relid=0 | w=20
  103. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of gastrointestinal disorder medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of gastrointestinal disorder medication action plan | rel=r_associated | relid=0 | w=20
  104. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of infectious disease medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of infectious disease medication action plan | rel=r_associated | relid=0 | w=20
  105. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of metabolic disorder medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of metabolic disorder medication action plan | rel=r_associated | relid=0 | w=20
  106. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of neurologic disorder medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of neurologic disorder medication action plan | rel=r_associated | relid=0 | w=20
  107. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of pain medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of pain medication action plan | rel=r_associated | relid=0 | w=20
  108. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of pregnancy and lactation medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of pregnancy and lactation medication action plan | rel=r_associated | relid=0 | w=20
  109. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of pulmonary disorder medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of pulmonary disorder medication action plan | rel=r_associated | relid=0 | w=20
  110. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:documentation of renal disorder medication action plan
    n1=en:telehealth obesity monitoring | n2=en:documentation of renal disorder medication action plan | rel=r_associated | relid=0 | w=20
  111. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:domestic partner abuse prevention
    n1=en:telehealth obesity monitoring | n2=en:domestic partner abuse prevention | rel=r_associated | relid=0 | w=20
  112. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:downs screening test
    n1=en:telehealth obesity monitoring | n2=en:downs screening test | rel=r_associated | relid=0 | w=20
  113. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:drainage of subretinal fluid after choroidal detachment
    n1=en:telehealth obesity monitoring | n2=en:drainage of subretinal fluid after choroidal detachment | rel=r_associated | relid=0 | w=20
  114. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:drainage of suprachoroidal fluid after choroidal detachment
    n1=en:telehealth obesity monitoring | n2=en:drainage of suprachoroidal fluid after choroidal detachment | rel=r_associated | relid=0 | w=20
  115. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:dysphasia assessment
    n1=en:telehealth obesity monitoring | n2=en:dysphasia assessment | rel=r_associated | relid=0 | w=20
  116. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about brachycephaly
    n1=en:telehealth obesity monitoring | n2=en:education about brachycephaly | rel=r_associated | relid=0 | w=20
  117. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about cardiovascular disease
    n1=en:telehealth obesity monitoring | n2=en:education about cardiovascular disease | rel=r_associated | relid=0 | w=20
  118. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about endocrine disorder
    n1=en:telehealth obesity monitoring | n2=en:education about endocrine disorder | rel=r_associated | relid=0 | w=20
  119. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about gastrointestinal disorder
    n1=en:telehealth obesity monitoring | n2=en:education about gastrointestinal disorder | rel=r_associated | relid=0 | w=20
  120. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about genitourinary disorder
    n1=en:telehealth obesity monitoring | n2=en:education about genitourinary disorder | rel=r_associated | relid=0 | w=20
  121. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about hematologic disorder
    n1=en:telehealth obesity monitoring | n2=en:education about hematologic disorder | rel=r_associated | relid=0 | w=20
  122. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about immune disorder
    n1=en:telehealth obesity monitoring | n2=en:education about immune disorder | rel=r_associated | relid=0 | w=20
  123. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about infectious disease
    n1=en:telehealth obesity monitoring | n2=en:education about infectious disease | rel=r_associated | relid=0 | w=20
  124. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about metabolic disease
    n1=en:telehealth obesity monitoring | n2=en:education about metabolic disease | rel=r_associated | relid=0 | w=20
  125. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about neurologic disorder
    n1=en:telehealth obesity monitoring | n2=en:education about neurologic disorder | rel=r_associated | relid=0 | w=20
  126. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about oral contraception
    n1=en:telehealth obesity monitoring | n2=en:education about oral contraception | rel=r_associated | relid=0 | w=20
  127. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about plagiocephaly
    n1=en:telehealth obesity monitoring | n2=en:education about plagiocephaly | rel=r_associated | relid=0 | w=20
  128. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about post term pregnancy
    n1=en:telehealth obesity monitoring | n2=en:education about post term pregnancy | rel=r_associated | relid=0 | w=20
  129. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about postpartum depression
    n1=en:telehealth obesity monitoring | n2=en:education about postpartum depression | rel=r_associated | relid=0 | w=20
  130. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about respiratory disorder
    n1=en:telehealth obesity monitoring | n2=en:education about respiratory disorder | rel=r_associated | relid=0 | w=20
  131. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:education about vaginal birth after cesarean section
    n1=en:telehealth obesity monitoring | n2=en:education about vaginal birth after cesarean section | rel=r_associated | relid=0 | w=20
  132. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:electromyography for disorder of central nervous system
    n1=en:telehealth obesity monitoring | n2=en:electromyography for disorder of central nervous system | rel=r_associated | relid=0 | w=20
  133. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:emergency contraception education
    n1=en:telehealth obesity monitoring | n2=en:emergency contraception education | rel=r_associated | relid=0 | w=20
  134. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:endoscopic serial drainage of amniotic fluid for twin-twin transfusion syndrome
    n1=en:telehealth obesity monitoring | n2=en:endoscopic serial drainage of amniotic fluid for twin-twin transfusion syndrome | rel=r_associated | relid=0 | w=20
  135. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:endoscopy of nasal sinus with control of nasal hemorrhage
    n1=en:telehealth obesity monitoring | n2=en:endoscopy of nasal sinus with control of nasal hemorrhage | rel=r_associated | relid=0 | w=20
  136. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:evaluation for signs and symptoms of chemical injury
    n1=en:telehealth obesity monitoring | n2=en:evaluation for signs and symptoms of chemical injury | rel=r_associated | relid=0 | w=20
  137. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:evaluation for signs and symptoms of electrical injury
    n1=en:telehealth obesity monitoring | n2=en:evaluation for signs and symptoms of electrical injury | rel=r_associated | relid=0 | w=20
  138. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:evaluation for signs and symptoms of injury as a result of positioning
    n1=en:telehealth obesity monitoring | n2=en:evaluation for signs and symptoms of injury as a result of positioning | rel=r_associated | relid=0 | w=20
  139. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:evaluation for signs and symptoms of laser injury
    n1=en:telehealth obesity monitoring | n2=en:evaluation for signs and symptoms of laser injury | rel=r_associated | relid=0 | w=20
  140. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:evaluation for signs and symptoms of physical injury to skin and tissue
    n1=en:telehealth obesity monitoring | n2=en:evaluation for signs and symptoms of physical injury to skin and tissue | rel=r_associated | relid=0 | w=20
  141. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:evaluation of ulcer healing
    n1=en:telehealth obesity monitoring | n2=en:evaluation of ulcer healing | rel=r_associated | relid=0 | w=20
  142. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:evaluation of wound healing progress
    n1=en:telehealth obesity monitoring | n2=en:evaluation of wound healing progress | rel=r_associated | relid=0 | w=20
  143. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:falls education
    n1=en:telehealth obesity monitoring | n2=en:falls education | rel=r_associated | relid=0 | w=20
  144. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:fecal impaction care
    n1=en:telehealth obesity monitoring | n2=en:fecal impaction care | rel=r_associated | relid=0 | w=20
  145. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:financial resource assistance
    n1=en:telehealth obesity monitoring | n2=en:financial resource assistance | rel=r_associated | relid=0 | w=20
  146. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:follow-up obesity assessment
    n1=en:telehealth obesity monitoring | n2=en:follow-up obesity assessment | rel=r_associated | relid=0 | w=20
  147. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:fracture care
    n1=en:telehealth obesity monitoring | n2=en:fracture care | rel=r_associated | relid=0 | w=20
  148. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:frail elderly assessment
    n1=en:telehealth obesity monitoring | n2=en:frail elderly assessment | rel=r_associated | relid=0 | w=20
  149. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:gated computed tomography of heart with contrast for congenital heart disease
    n1=en:telehealth obesity monitoring | n2=en:gated computed tomography of heart with contrast for congenital heart disease | rel=r_associated | relid=0 | w=20
  150. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:genetics education, guidance, counseling
    n1=en:telehealth obesity monitoring | n2=en:genetics education, guidance, counseling | rel=r_associated | relid=0 | w=20
  151. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:genetics evaluation surveillance
    n1=en:telehealth obesity monitoring | n2=en:genetics evaluation surveillance | rel=r_associated | relid=0 | w=20
  152. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:geriatric syndrome education
    n1=en:telehealth obesity monitoring | n2=en:geriatric syndrome education | rel=r_associated | relid=0 | w=20
  153. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:heart failure education
    n1=en:telehealth obesity monitoring | n2=en:heart failure education | rel=r_associated | relid=0 | w=20
  154. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:hemochromatosis gene screening test
    n1=en:telehealth obesity monitoring | n2=en:hemochromatosis gene screening test | rel=r_associated | relid=0 | w=20
  155. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:hemoglobinopathy education
    n1=en:telehealth obesity monitoring | n2=en:hemoglobinopathy education | rel=r_associated | relid=0 | w=20
  156. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:hemoglobinopathy screening test
    n1=en:telehealth obesity monitoring | n2=en:hemoglobinopathy screening test | rel=r_associated | relid=0 | w=20
  157. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:homosexuality counseling
    n1=en:telehealth obesity monitoring | n2=en:homosexuality counseling | rel=r_associated | relid=0 | w=20
  158. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:hyperventilation therapy for traumatic brain injury
    n1=en:telehealth obesity monitoring | n2=en:hyperventilation therapy for traumatic brain injury | rel=r_associated | relid=0 | w=20
  159. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:hypoglycemia education
    n1=en:telehealth obesity monitoring | n2=en:hypoglycemia education | rel=r_associated | relid=0 | w=20
  160. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:ict malaria screening test
    n1=en:telehealth obesity monitoring | n2=en:ict malaria screening test | rel=r_associated | relid=0 | w=20
  161. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:implantation of carmustine wafer into cerebrum
    n1=en:telehealth obesity monitoring | n2=en:implantation of carmustine wafer into cerebrum | rel=r_associated | relid=0 | w=20
  162. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:implementation of protective measures to prevent injury due to electrical sources
    n1=en:telehealth obesity monitoring | n2=en:implementation of protective measures to prevent injury due to electrical sources | rel=r_associated | relid=0 | w=20
  163. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:implementation of protective measures to prevent injury due to laser sources
    n1=en:telehealth obesity monitoring | n2=en:implementation of protective measures to prevent injury due to laser sources | rel=r_associated | relid=0 | w=20
  164. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:implementation of protective measures to prevent injury due to radiation sources
    n1=en:telehealth obesity monitoring | n2=en:implementation of protective measures to prevent injury due to radiation sources | rel=r_associated | relid=0 | w=20
  165. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:implementation of protective measures to prevent skin and tissue injury due to chemical sources
    n1=en:telehealth obesity monitoring | n2=en:implementation of protective measures to prevent skin and tissue injury due to chemical sources | rel=r_associated | relid=0 | w=20
  166. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:implementation of protective measures to prevent skin or tissue injury due to mechanical sources
    n1=en:telehealth obesity monitoring | n2=en:implementation of protective measures to prevent skin or tissue injury due to mechanical sources | rel=r_associated | relid=0 | w=20
  167. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:implementation of protective measures to prevent skin or tissue injury due to thermal sources
    n1=en:telehealth obesity monitoring | n2=en:implementation of protective measures to prevent skin or tissue injury due to thermal sources | rel=r_associated | relid=0 | w=20
  168. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:impotence education
    n1=en:telehealth obesity monitoring | n2=en:impotence education | rel=r_associated | relid=0 | w=20
  169. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:initial obesity assessment
    n1=en:telehealth obesity monitoring | n2=en:initial obesity assessment | rel=r_associated | relid=0 | w=20
  170. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:injection hemostasis of duodenal lesion
    n1=en:telehealth obesity monitoring | n2=en:injection hemostasis of duodenal lesion | rel=r_associated | relid=0 | w=20
  171. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:injection hemostasis of gastric lesion
    n1=en:telehealth obesity monitoring | n2=en:injection hemostasis of gastric lesion | rel=r_associated | relid=0 | w=20
  172. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:injection of anesthetic into periorbital region for akinesia
    n1=en:telehealth obesity monitoring | n2=en:injection of anesthetic into periorbital region for akinesia | rel=r_associated | relid=0 | w=20
  173. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:laparoscopy for undescended testicle
    n1=en:telehealth obesity monitoring | n2=en:laparoscopy for undescended testicle | rel=r_associated | relid=0 | w=20
  174. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:lymphedema care
    n1=en:telehealth obesity monitoring | n2=en:lymphedema care | rel=r_associated | relid=0 | w=20
  175. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:maintaining confidentiality of patient information
    n1=en:telehealth obesity monitoring | n2=en:maintaining confidentiality of patient information | rel=r_associated | relid=0 | w=20
  176. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:management of depressed mood with postpartum onset
    n1=en:telehealth obesity monitoring | n2=en:management of depressed mood with postpartum onset | rel=r_associated | relid=0 | w=20
  177. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:management of increased intracranial pressure
    n1=en:telehealth obesity monitoring | n2=en:management of increased intracranial pressure | rel=r_associated | relid=0 | w=20
  178. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:measurement of alpha fetoprotein as marker for malignant neoplasm
    n1=en:telehealth obesity monitoring | n2=en:measurement of alpha fetoprotein as marker for malignant neoplasm | rel=r_associated | relid=0 | w=20
  179. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:mechanical repair and refitting of spectacles for aphakia
    n1=en:telehealth obesity monitoring | n2=en:mechanical repair and refitting of spectacles for aphakia | rel=r_associated | relid=0 | w=20
  180. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:medication interaction with food education
    n1=en:telehealth obesity monitoring | n2=en:medication interaction with food education | rel=r_associated | relid=0 | w=20
  181. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:medication interaction with medication education
    n1=en:telehealth obesity monitoring | n2=en:medication interaction with medication education | rel=r_associated | relid=0 | w=20
  182. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:memory loss care
    n1=en:telehealth obesity monitoring | n2=en:memory loss care | rel=r_associated | relid=0 | w=20
  183. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:metabolic screening test
    n1=en:telehealth obesity monitoring | n2=en:metabolic screening test | rel=r_associated | relid=0 | w=20
  184. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:monitoring - action
    n1=en:telehealth obesity monitoring | n2=en:monitoring - action | rel=r_associated | relid=0 | w=20
  185. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:monitoring of blood pressure, temperature, pulse rate and respiratory rate
    n1=en:telehealth obesity monitoring | n2=en:monitoring of blood pressure, temperature, pulse rate and respiratory rate | rel=r_associated | relid=0 | w=20
  186. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:nausea care
    n1=en:telehealth obesity monitoring | n2=en:nausea care | rel=r_associated | relid=0 | w=20
  187. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:nutrition therapy for congestive heart failure
    n1=en:telehealth obesity monitoring | n2=en:nutrition therapy for congestive heart failure | rel=r_associated | relid=0 | w=20
  188. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:nutrition therapy for hypertension
    n1=en:telehealth obesity monitoring | n2=en:nutrition therapy for hypertension | rel=r_associated | relid=0 | w=20
  189. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:occlusion therapy
    n1=en:telehealth obesity monitoring | n2=en:occlusion therapy | rel=r_associated | relid=0 | w=20
  190. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:opioid medication review
    n1=en:telehealth obesity monitoring | n2=en:opioid medication review | rel=r_associated | relid=0 | w=20
  191. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:parenting promotion
    n1=en:telehealth obesity monitoring | n2=en:parenting promotion | rel=r_associated | relid=0 | w=20
  192. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:patient self-determination act education
    n1=en:telehealth obesity monitoring | n2=en:patient self-determination act education | rel=r_associated | relid=0 | w=20
  193. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:penalization therapy
    n1=en:telehealth obesity monitoring | n2=en:penalization therapy | rel=r_associated | relid=0 | w=20
  194. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:percutaneous electrical nerve stimulation of tibial nerve for urinary incontinence
    n1=en:telehealth obesity monitoring | n2=en:percutaneous electrical nerve stimulation of tibial nerve for urinary incontinence | rel=r_associated | relid=0 | w=20
  195. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:phobia counseling
    n1=en:telehealth obesity monitoring | n2=en:phobia counseling | rel=r_associated | relid=0 | w=20
  196. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:postoperative follow-up visit
    n1=en:telehealth obesity monitoring | n2=en:postoperative follow-up visit | rel=r_associated | relid=0 | w=20
  197. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:pregnancy and lactation education
    n1=en:telehealth obesity monitoring | n2=en:pregnancy and lactation education | rel=r_associated | relid=0 | w=20
  198. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:prescription of contraception
    n1=en:telehealth obesity monitoring | n2=en:prescription of contraception | rel=r_associated | relid=0 | w=20
  199. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:prevention of deep vein thrombosis
    n1=en:telehealth obesity monitoring | n2=en:prevention of deep vein thrombosis | rel=r_associated | relid=0 | w=20
  200. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:prevention of unwanted pregnancy
    n1=en:telehealth obesity monitoring | n2=en:prevention of unwanted pregnancy | rel=r_associated | relid=0 | w=20
  201. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:primary prevention of ischemic heart disease
    n1=en:telehealth obesity monitoring | n2=en:primary prevention of ischemic heart disease | rel=r_associated | relid=0 | w=20
  202. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:promotion of infertility
    n1=en:telehealth obesity monitoring | n2=en:promotion of infertility | rel=r_associated | relid=0 | w=20
  203. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:provision of written information about diabetes and high hemoglobin a1c level
    n1=en:telehealth obesity monitoring | n2=en:provision of written information about diabetes and high hemoglobin a1c level | rel=r_associated | relid=0 | w=20
  204. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:pruritus care
    n1=en:telehealth obesity monitoring | n2=en:pruritus care | rel=r_associated | relid=0 | w=20
  205. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:radionuclide imaging of small intestine for meckel diverticulum
    n1=en:telehealth obesity monitoring | n2=en:radionuclide imaging of small intestine for meckel diverticulum | rel=r_associated | relid=0 | w=20
  206. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:radionuclide pentavalent dimercaptosuccinic acid renal neoplasm study
    n1=en:telehealth obesity monitoring | n2=en:radionuclide pentavalent dimercaptosuccinic acid renal neoplasm study | rel=r_associated | relid=0 | w=20
  207. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:radionuclide study of thyroid for medullary thyroid carcinoma using pentavalent dimercaptosuccinic acid
    n1=en:telehealth obesity monitoring | n2=en:radionuclide study of thyroid for medullary thyroid carcinoma using pentavalent dimercaptosuccinic acid | rel=r_associated | relid=0 | w=20
  208. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:radionuclide study of whole body for detection of right to left shunt using macroaggregated albumin
    n1=en:telehealth obesity monitoring | n2=en:radionuclide study of whole body for detection of right to left shunt using macroaggregated albumin | rel=r_associated | relid=0 | w=20
  209. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral for bipolar disorder
    n1=en:telehealth obesity monitoring | n2=en:referral for bipolar disorder | rel=r_associated | relid=0 | w=20
  210. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral for hematuria
    n1=en:telehealth obesity monitoring | n2=en:referral for hematuria | rel=r_associated | relid=0 | w=20
  211. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral for perinatal home care
    n1=en:telehealth obesity monitoring | n2=en:referral for perinatal home care | rel=r_associated | relid=0 | w=20
  212. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral for proteinuria test
    n1=en:telehealth obesity monitoring | n2=en:referral for proteinuria test | rel=r_associated | relid=0 | w=20
  213. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral for substance abuse
    n1=en:telehealth obesity monitoring | n2=en:referral for substance abuse | rel=r_associated | relid=0 | w=20
  214. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral to pediatric cardiology service
    n1=en:telehealth obesity monitoring | n2=en:referral to pediatric cardiology service | rel=r_associated | relid=0 | w=20
  215. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral to pediatric dermatology service
    n1=en:telehealth obesity monitoring | n2=en:referral to pediatric dermatology service | rel=r_associated | relid=0 | w=20
  216. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral to rheumatology service for osteoarthritis
    n1=en:telehealth obesity monitoring | n2=en:referral to rheumatology service for osteoarthritis | rel=r_associated | relid=0 | w=20
  217. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral to urology service for elevated psa
    n1=en:telehealth obesity monitoring | n2=en:referral to urology service for elevated psa | rel=r_associated | relid=0 | w=20
  218. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral to urology service for hematuria
    n1=en:telehealth obesity monitoring | n2=en:referral to urology service for hematuria | rel=r_associated | relid=0 | w=20
  219. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:referral to urology service for recurrent female urinary tract infection
    n1=en:telehealth obesity monitoring | n2=en:referral to urology service for recurrent female urinary tract infection | rel=r_associated | relid=0 | w=20
  220. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:religious exploitation prevention
    n1=en:telehealth obesity monitoring | n2=en:religious exploitation prevention | rel=r_associated | relid=0 | w=20
  221. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:rotavirus screening test
    n1=en:telehealth obesity monitoring | n2=en:rotavirus screening test | rel=r_associated | relid=0 | w=20
  222. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:rubella screening test
    n1=en:telehealth obesity monitoring | n2=en:rubella screening test | rel=r_associated | relid=0 | w=20
  223. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:screening for abuse
    n1=en:telehealth obesity monitoring | n2=en:screening for abuse | rel=r_associated | relid=0 | w=20
  224. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:screening for disorder
    n1=en:telehealth obesity monitoring | n2=en:screening for disorder | rel=r_associated | relid=0 | w=20
  225. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:serial drainage of amniotic fluid for twin-twin transfusion syndrome
    n1=en:telehealth obesity monitoring | n2=en:serial drainage of amniotic fluid for twin-twin transfusion syndrome | rel=r_associated | relid=0 | w=20
  226. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:stress counseling
    n1=en:telehealth obesity monitoring | n2=en:stress counseling | rel=r_associated | relid=0 | w=20
  227. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:substance abuse prevention
    n1=en:telehealth obesity monitoring | n2=en:substance abuse prevention | rel=r_associated | relid=0 | w=20
  228. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:taking orthostatic vital signs
    n1=en:telehealth obesity monitoring | n2=en:taking orthostatic vital signs | rel=r_associated | relid=0 | w=20
  229. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:target weight discussed
    n1=en:telehealth obesity monitoring | n2=en:target weight discussed | rel=r_associated | relid=0 | w=20
  230. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:toxoplasma screening test
    n1=en:telehealth obesity monitoring | n2=en:toxoplasma screening test | rel=r_associated | relid=0 | w=20
  231. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:transesophageal echocardiography for congenital heart disease
    n1=en:telehealth obesity monitoring | n2=en:transesophageal echocardiography for congenital heart disease | rel=r_associated | relid=0 | w=20
  232. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:transluminal intracardiac echocardiography for congenital heart disease
    n1=en:telehealth obesity monitoring | n2=en:transluminal intracardiac echocardiography for congenital heart disease | rel=r_associated | relid=0 | w=20
  233. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:transthoracic echocardiography for congenital heart disease
    n1=en:telehealth obesity monitoring | n2=en:transthoracic echocardiography for congenital heart disease | rel=r_associated | relid=0 | w=20
  234. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:treatment for osteoporosis
    n1=en:telehealth obesity monitoring | n2=en:treatment for osteoporosis | rel=r_associated | relid=0 | w=20
  235. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:treponema screening test
    n1=en:telehealth obesity monitoring | n2=en:treponema screening test | rel=r_associated | relid=0 | w=20
  236. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:tuberculosis community education
    n1=en:telehealth obesity monitoring | n2=en:tuberculosis community education | rel=r_associated | relid=0 | w=20
  237. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:urine screen for chlamydia
    n1=en:telehealth obesity monitoring | n2=en:urine screen for chlamydia | rel=r_associated | relid=0 | w=20
  238. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:vascular disease risk assessment
    n1=en:telehealth obesity monitoring | n2=en:vascular disease risk assessment | rel=r_associated | relid=0 | w=20
  239. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:verification of allergy status
    n1=en:telehealth obesity monitoring | n2=en:verification of allergy status | rel=r_associated | relid=0 | w=20
  240. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:vomiting management
    n1=en:telehealth obesity monitoring | n2=en:vomiting management | rel=r_associated | relid=0 | w=20
  241. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:von willebrand screening test
    n1=en:telehealth obesity monitoring | n2=en:von willebrand screening test | rel=r_associated | relid=0 | w=20
  242. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:wandering precautions
    n1=en:telehealth obesity monitoring | n2=en:wandering precautions | rel=r_associated | relid=0 | w=20
  243. en:telehealth obesity monitoring -- r_associated #0: 20 / 0.488 -> en:x-ray skeletal survey for multiple myeloma
    n1=en:telehealth obesity monitoring | n2=en:x-ray skeletal survey for multiple myeloma | rel=r_associated | relid=0 | w=20
≈ 244 relations entrantes

  1. en:target weight discussed --- r_associated #0: 43 --> en:telehealth obesity monitoring
    n1=en:target weight discussed | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=43
  2. en:allergy management --- r_associated #0: 42 --> en:telehealth obesity monitoring
    n1=en:allergy management | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=42
  3. en:domestic partner abuse prevention --- r_associated #0: 42 --> en:telehealth obesity monitoring
    n1=en:domestic partner abuse prevention | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=42
  4. en:assessment of lymphedema --- r_associated #0: 41 --> en:telehealth obesity monitoring
    n1=en:assessment of lymphedema | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=41
  5. en:chronic disease process education --- r_associated #0: 40 --> en:telehealth obesity monitoring
    n1=en:chronic disease process education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=40
  6. en:documentation of infectious disease medication action plan --- r_associated #0: 39 --> en:telehealth obesity monitoring
    n1=en:documentation of infectious disease medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=39
  7. en:treponema screening test --- r_associated #0: 39 --> en:telehealth obesity monitoring
    n1=en:treponema screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=39
  8. en:circulatory care: venous insufficency --- r_associated #0: 37 --> en:telehealth obesity monitoring
    n1=en:circulatory care: venous insufficency | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=37
  9. en:assessment of raised intracranial pressure --- r_associated #0: 36 --> en:telehealth obesity monitoring
    n1=en:assessment of raised intracranial pressure | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=36
  10. en:consultation for transition of care --- r_associated #0: 36 --> en:telehealth obesity monitoring
    n1=en:consultation for transition of care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=36
  11. en:medication interaction with food education --- r_associated #0: 36 --> en:telehealth obesity monitoring
    n1=en:medication interaction with food education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=36
  12. en:screening for disorder --- r_associated #0: 36 --> en:telehealth obesity monitoring
    n1=en:screening for disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=36
  13. en:allergy screening test --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:allergy screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  14. en:assessment for risk of cardiovascular disease --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:assessment for risk of cardiovascular disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  15. en:assessment of chest pain --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:assessment of chest pain | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  16. en:assessment of diabetic erectile dysfunction --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:assessment of diabetic erectile dysfunction | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  17. en:counseling about disease --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:counseling about disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  18. en:counseling for menopause --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:counseling for menopause | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  19. en:developmental enhancement: child --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:developmental enhancement: child | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  20. en:discussion about vaginal bleeding --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:discussion about vaginal bleeding | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  21. en:documentation of gastrointestinal disorder medication action plan --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:documentation of gastrointestinal disorder medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  22. en:drainage of subretinal fluid after choroidal detachment --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:drainage of subretinal fluid after choroidal detachment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  23. en:education about respiratory disorder --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:education about respiratory disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  24. en:evaluation of ulcer healing --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:evaluation of ulcer healing | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  25. en:injection hemostasis of gastric lesion --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:injection hemostasis of gastric lesion | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  26. en:lymphedema care --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:lymphedema care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  27. en:management of depressed mood with postpartum onset --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:management of depressed mood with postpartum onset | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  28. en:medication interaction with medication education --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:medication interaction with medication education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  29. en:memory loss care --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:memory loss care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  30. en:monitoring - action --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:monitoring - action | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  31. en:monitoring of blood pressure, temperature, pulse rate and respiratory rate --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:monitoring of blood pressure, temperature, pulse rate and respiratory rate | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  32. en:prevention of deep vein thrombosis --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:prevention of deep vein thrombosis | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  33. en:referral to pediatric dermatology service --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:referral to pediatric dermatology service | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  34. en:referral to rheumatology service for osteoarthritis --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:referral to rheumatology service for osteoarthritis | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  35. en:religious exploitation prevention --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:religious exploitation prevention | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  36. en:tuberculosis community education --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:tuberculosis community education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  37. en:urine screen for chlamydia --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:urine screen for chlamydia | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  38. en:von willebrand screening test --- r_associated #0: 35 --> en:telehealth obesity monitoring
    n1=en:von willebrand screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=35
  39. en:assessment of substance use --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:assessment of substance use | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  40. en:atypical pneumonia screening test --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:atypical pneumonia screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  41. en:diabetic erectile dysfunction review --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:diabetic erectile dysfunction review | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  42. en:documentation of pulmonary disorder medication action plan --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:documentation of pulmonary disorder medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  43. en:endoscopy of nasal sinus with control of nasal hemorrhage --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:endoscopy of nasal sinus with control of nasal hemorrhage | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  44. en:gated computed tomography of heart with contrast for congenital heart disease --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:gated computed tomography of heart with contrast for congenital heart disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  45. en:genetics evaluation surveillance --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:genetics evaluation surveillance | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  46. en:initial obesity assessment --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:initial obesity assessment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  47. en:metabolic screening test --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:metabolic screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  48. en:pregnancy and lactation education --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:pregnancy and lactation education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  49. en:provision of written information about diabetes and high hemoglobin a1c level --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:provision of written information about diabetes and high hemoglobin a1c level | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  50. en:radionuclide study of thyroid for medullary thyroid carcinoma using pentavalent dimercaptosuccinic acid --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:radionuclide study of thyroid for medullary thyroid carcinoma using pentavalent dimercaptosuccinic acid | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  51. en:referral to urology service for hematuria --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:referral to urology service for hematuria | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  52. en:referral to urology service for recurrent female urinary tract infection --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:referral to urology service for recurrent female urinary tract infection | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  53. en:substance abuse prevention --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:substance abuse prevention | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  54. en:transluminal intracardiac echocardiography for congenital heart disease --- r_associated #0: 34 --> en:telehealth obesity monitoring
    n1=en:transluminal intracardiac echocardiography for congenital heart disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=34
  55. en:amniocentesis for possible chromosomal abnormality --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:amniocentesis for possible chromosomal abnormality | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  56. en:assessment of pre-existing conditions that predispose to inadequate tissue perfusion --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:assessment of pre-existing conditions that predispose to inadequate tissue perfusion | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  57. en:depression management program --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:depression management program | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  58. en:determination of resuscitation status --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:determination of resuscitation status | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  59. en:documentation of renal disorder medication action plan --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:documentation of renal disorder medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  60. en:drainage of suprachoroidal fluid after choroidal detachment --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:drainage of suprachoroidal fluid after choroidal detachment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  61. en:education about cardiovascular disease --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:education about cardiovascular disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  62. en:education about gastrointestinal disorder --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:education about gastrointestinal disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  63. en:education about neurologic disorder --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:education about neurologic disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  64. en:electromyography for disorder of central nervous system --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:electromyography for disorder of central nervous system | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  65. en:frail elderly assessment --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:frail elderly assessment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  66. en:hypoglycemia education --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:hypoglycemia education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  67. en:implementation of protective measures to prevent injury due to radiation sources --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:implementation of protective measures to prevent injury due to radiation sources | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  68. en:nutrition therapy for hypertension --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:nutrition therapy for hypertension | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  69. en:opioid medication review --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:opioid medication review | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  70. en:penalization therapy --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:penalization therapy | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  71. en:prevention of unwanted pregnancy --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:prevention of unwanted pregnancy | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  72. en:primary prevention of ischemic heart disease --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:primary prevention of ischemic heart disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  73. en:promotion of infertility --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:promotion of infertility | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  74. en:referral for proteinuria test --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:referral for proteinuria test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  75. en:transesophageal echocardiography for congenital heart disease --- r_associated #0: 32 --> en:telehealth obesity monitoring
    n1=en:transesophageal echocardiography for congenital heart disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=32
  76. en:anxiety counseling --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:anxiety counseling | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  77. en:child abuse prevention --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:child abuse prevention | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  78. en:coronary heart disease education --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:coronary heart disease education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  79. en:counseling about fear --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:counseling about fear | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  80. en:counseling for alternatives to driving --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:counseling for alternatives to driving | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  81. en:documentation of pregnancy and lactation medication action plan --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:documentation of pregnancy and lactation medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  82. en:education about immune disorder --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:education about immune disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  83. en:education about postpartum depression --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:education about postpartum depression | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  84. en:emergency contraception education --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:emergency contraception education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  85. en:evaluation of wound healing progress --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:evaluation of wound healing progress | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  86. en:injection of anesthetic into periorbital region for akinesia --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:injection of anesthetic into periorbital region for akinesia | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  87. en:pruritus care --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:pruritus care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  88. en:referral for substance abuse --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:referral for substance abuse | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  89. en:stress counseling --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:stress counseling | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  90. en:transthoracic echocardiography for congenital heart disease --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:transthoracic echocardiography for congenital heart disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  91. en:x-ray skeletal survey for multiple myeloma --- r_associated #0: 31 --> en:telehealth obesity monitoring
    n1=en:x-ray skeletal survey for multiple myeloma | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=31
  92. en:alcohol brief intervention --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:alcohol brief intervention | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  93. en:assessment of need for interpreter --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:assessment of need for interpreter | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  94. en:asthma education --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:asthma education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  95. en:circulatory care: arterial insufficiency --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:circulatory care: arterial insufficiency | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  96. en:conflict mediation --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:conflict mediation | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  97. en:constipation care --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:constipation care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  98. en:crime victim counseling --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:crime victim counseling | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  99. en:documentation of cardiovascular disorder medication action plan --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:documentation of cardiovascular disorder medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  100. en:documentation of pain medication action plan --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:documentation of pain medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  101. en:downs screening test --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:downs screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  102. en:education about genitourinary disorder --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:education about genitourinary disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  103. en:endoscopic serial drainage of amniotic fluid for twin-twin transfusion syndrome --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:endoscopic serial drainage of amniotic fluid for twin-twin transfusion syndrome | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  104. en:evaluation for signs and symptoms of injury as a result of positioning --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:evaluation for signs and symptoms of injury as a result of positioning | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  105. en:fecal impaction care --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:fecal impaction care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  106. en:financial resource assistance --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:financial resource assistance | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  107. en:maintaining confidentiality of patient information --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:maintaining confidentiality of patient information | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  108. en:management of increased intracranial pressure --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:management of increased intracranial pressure | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  109. en:nausea care --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:nausea care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  110. en:prescription of contraception --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:prescription of contraception | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  111. en:referral for perinatal home care --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:referral for perinatal home care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  112. en:referral to pediatric cardiology service --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:referral to pediatric cardiology service | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  113. en:rotavirus screening test --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:rotavirus screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  114. en:treatment for osteoporosis --- r_associated #0: 30 --> en:telehealth obesity monitoring
    n1=en:treatment for osteoporosis | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=30
  115. en:administration of prescribed medications based on arterial blood gas results --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:administration of prescribed medications based on arterial blood gas results | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  116. en:adverse drug reaction prevention --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:adverse drug reaction prevention | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  117. en:amniocentesis for possible neural tube defect --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:amniocentesis for possible neural tube defect | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  118. en:congenital hypothyroidism screening test --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:congenital hypothyroidism screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  119. en:counseling for unwanted pregnancy --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:counseling for unwanted pregnancy | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  120. en:documentation of metabolic disorder medication action plan --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:documentation of metabolic disorder medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  121. en:documentation of neurologic disorder medication action plan --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:documentation of neurologic disorder medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  122. en:education about endocrine disorder --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:education about endocrine disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  123. en:education about hematologic disorder --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:education about hematologic disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  124. en:education about post term pregnancy --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:education about post term pregnancy | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  125. en:hemochromatosis gene screening test --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:hemochromatosis gene screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  126. en:homosexuality counseling --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:homosexuality counseling | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  127. en:nutrition therapy for congestive heart failure --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:nutrition therapy for congestive heart failure | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  128. en:percutaneous electrical nerve stimulation of tibial nerve for urinary incontinence --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:percutaneous electrical nerve stimulation of tibial nerve for urinary incontinence | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  129. en:referral to urology service for elevated psa --- r_associated #0: 29 --> en:telehealth obesity monitoring
    n1=en:referral to urology service for elevated psa | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=29
  130. en:carotid sinus massage test --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:carotid sinus massage test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  131. en:diarrhea care --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:diarrhea care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  132. en:dysphasia assessment --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:dysphasia assessment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  133. en:education about brachycephaly --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:education about brachycephaly | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  134. en:evaluation for signs and symptoms of electrical injury --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:evaluation for signs and symptoms of electrical injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  135. en:evaluation for signs and symptoms of physical injury to skin and tissue --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:evaluation for signs and symptoms of physical injury to skin and tissue | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  136. en:genetics education, guidance, counseling --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:genetics education, guidance, counseling | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  137. en:heart failure education --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:heart failure education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  138. en:hyperventilation therapy for traumatic brain injury --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:hyperventilation therapy for traumatic brain injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  139. en:implantation of carmustine wafer into cerebrum --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:implantation of carmustine wafer into cerebrum | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  140. en:injection hemostasis of duodenal lesion --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:injection hemostasis of duodenal lesion | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  141. en:laparoscopy for undescended testicle --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:laparoscopy for undescended testicle | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  142. en:occlusion therapy --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:occlusion therapy | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  143. en:parenting promotion --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:parenting promotion | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  144. en:screening for abuse --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:screening for abuse | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  145. en:vascular disease risk assessment --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:vascular disease risk assessment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  146. en:verification of allergy status --- r_associated #0: 28 --> en:telehealth obesity monitoring
    n1=en:verification of allergy status | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=28
  147. en:amniotic fluid analysis for hemolytic disease of the newborn --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:amniotic fluid analysis for hemolytic disease of the newborn | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  148. en:assessment of dementia --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:assessment of dementia | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  149. en:assessment of skin integrity --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:assessment of skin integrity | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  150. en:counseling about tobacco use --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:counseling about tobacco use | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  151. en:counseling for risks of driving --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:counseling for risks of driving | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  152. en:documentation of endocrine disorder medication action plan --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:documentation of endocrine disorder medication action plan | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  153. en:education about infectious disease --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:education about infectious disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  154. en:education about metabolic disease --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:education about metabolic disease | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  155. en:education about vaginal birth after cesarean section --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:education about vaginal birth after cesarean section | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  156. en:evaluation for signs and symptoms of laser injury --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:evaluation for signs and symptoms of laser injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  157. en:falls education --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:falls education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  158. en:follow-up obesity assessment --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:follow-up obesity assessment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  159. en:fracture care --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:fracture care | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  160. en:hemoglobinopathy screening test --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:hemoglobinopathy screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  161. en:ict malaria screening test --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:ict malaria screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  162. en:implementation of protective measures to prevent injury due to electrical sources --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:implementation of protective measures to prevent injury due to electrical sources | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  163. en:implementation of protective measures to prevent injury due to laser sources --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:implementation of protective measures to prevent injury due to laser sources | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  164. en:implementation of protective measures to prevent skin and tissue injury due to chemical sources --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:implementation of protective measures to prevent skin and tissue injury due to chemical sources | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  165. en:measurement of alpha fetoprotein as marker for malignant neoplasm --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:measurement of alpha fetoprotein as marker for malignant neoplasm | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  166. en:phobia counseling --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:phobia counseling | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  167. en:postoperative follow-up visit --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:postoperative follow-up visit | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  168. en:radionuclide imaging of small intestine for meckel diverticulum --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:radionuclide imaging of small intestine for meckel diverticulum | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  169. en:radionuclide pentavalent dimercaptosuccinic acid renal neoplasm study --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:radionuclide pentavalent dimercaptosuccinic acid renal neoplasm study | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  170. en:radionuclide study of whole body for detection of right to left shunt using macroaggregated albumin --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:radionuclide study of whole body for detection of right to left shunt using macroaggregated albumin | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  171. en:referral for bipolar disorder --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:referral for bipolar disorder | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  172. en:serial drainage of amniotic fluid for twin-twin transfusion syndrome --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:serial drainage of amniotic fluid for twin-twin transfusion syndrome | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  173. en:taking orthostatic vital signs --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:taking orthostatic vital signs | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  174. en:toxoplasma screening test --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:toxoplasma screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  175. en:vomiting management --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:vomiting management | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  176. en:wandering precautions --- r_associated #0: 27 --> en:telehealth obesity monitoring
    n1=en:wandering precautions | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=27
  177. en:administration of prophylactic agent after sexual exposure --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:administration of prophylactic agent after sexual exposure | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  178. en:assessment of adverse drug reactions --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:assessment of adverse drug reactions | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  179. en:assessment of body movement --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:assessment of body movement | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  180. en:assessment of mood --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:assessment of mood | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  181. en:counseling about spiritual distress --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:counseling about spiritual distress | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  182. en:education about oral contraception --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:education about oral contraception | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  183. en:education about plagiocephaly --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:education about plagiocephaly | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  184. en:evaluation for signs and symptoms of chemical injury --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:evaluation for signs and symptoms of chemical injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  185. en:geriatric syndrome education --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:geriatric syndrome education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  186. en:hemoglobinopathy education --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:hemoglobinopathy education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  187. en:implementation of protective measures to prevent skin or tissue injury due to mechanical sources --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:implementation of protective measures to prevent skin or tissue injury due to mechanical sources | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  188. en:implementation of protective measures to prevent skin or tissue injury due to thermal sources --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:implementation of protective measures to prevent skin or tissue injury due to thermal sources | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  189. en:impotence education --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:impotence education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  190. en:mechanical repair and refitting of spectacles for aphakia --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:mechanical repair and refitting of spectacles for aphakia | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  191. en:patient self-determination act education --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:patient self-determination act education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  192. en:referral for hematuria --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:referral for hematuria | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  193. en:rubella screening test --- r_associated #0: 26 --> en:telehealth obesity monitoring
    n1=en:rubella screening test | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=26
  194. en:acid-base management: respiratory acidosis --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:acid-base management: respiratory acidosis | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  195. en:acid-base regulation: metabolic acidosis --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:acid-base regulation: metabolic acidosis | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  196. en:activity of daily living procedures and interventions --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:activity of daily living procedures and interventions | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  197. en:alcohol consumption screening --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:alcohol consumption screening | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  198. en:allergy education --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:allergy education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  199. en:allergy medication review --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:allergy medication review | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  200. en:amniotic fluid analysis for erythroblastosis fetalis --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:amniotic fluid analysis for erythroblastosis fetalis | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  201. en:anesthesia for abdominal wound dehiscence --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:anesthesia for abdominal wound dehiscence | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  202. en:anesthesia for pectus excavatum --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:anesthesia for pectus excavatum | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  203. en:anesthesia for vaginal delivery --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:anesthesia for vaginal delivery | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  204. en:antenatal risk assessment --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:antenatal risk assessment | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  205. en:arthritis medication review --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:arthritis medication review | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  206. en:aspiration precautions --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:aspiration precautions | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  207. en:assessment for risk of cancer --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment for risk of cancer | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  208. en:assessment for risk of harm to others --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment for risk of harm to others | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  209. en:assessment of ability to prepare food --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of ability to prepare food | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  210. en:assessment of allodynia --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of allodynia | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  211. en:assessment of appetite --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of appetite | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  212. en:assessment of breastfeeding --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of breastfeeding | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  213. en:assessment of dizziness --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of dizziness | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  214. en:assessment of fatigue --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of fatigue | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  215. en:assessment of hyperalgesia --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of hyperalgesia | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  216. en:assessment of laser injury --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of laser injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  217. en:assessment of perioperative injury --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of perioperative injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  218. en:assessment of physiological status --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of physiological status | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  219. en:assessment of pregnancy status prior to imaging --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of pregnancy status prior to imaging | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  220. en:assessment of psychological response to pain --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of psychological response to pain | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  221. en:assessment of risk for dehydration --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of risk for dehydration | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  222. en:assessment of risk for falls on admission --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of risk for falls on admission | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  223. en:assessment of risk for impaired nutritional status --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of risk for impaired nutritional status | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  224. en:assessment of risk for transfer injury --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of risk for transfer injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  225. en:assessment of self esteem --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of self esteem | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  226. en:assessment of substance withdrawal --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment of substance withdrawal | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  227. en:assessment: respiration --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:assessment: respiration | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  228. en:barium enema for radiological reduction of intussusception of ileum --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:barium enema for radiological reduction of intussusception of ileum | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  229. en:bowel imaging for volvulus --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:bowel imaging for volvulus | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  230. en:cancer education --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:cancer education | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  231. en:cerebral edema management --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:cerebral edema management | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  232. en:chemotherapy for non-malignant neoplasm --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:chemotherapy for non-malignant neoplasm | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  233. en:clot retraction, screen --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:clot retraction, screen | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  234. en:contraceptive methods --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:contraceptive methods | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  235. en:correction of trichiasis by epilation with forceps --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:correction of trichiasis by epilation with forceps | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  236. en:counseling about diagnositic imaging findings --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:counseling about diagnositic imaging findings | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  237. en:counseling about physical activity --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:counseling about physical activity | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  238. en:counseling for infertility --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:counseling for infertility | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  239. en:crisis intervention --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:crisis intervention | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  240. en:ct of trunk for assessment for solid organ injury --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:ct of trunk for assessment for solid organ injury | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  241. en:delirium management --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:delirium management | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  242. en:dementia management --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:dementia management | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  243. en:dermatologic disorder medication review --- r_associated #0: 20 --> en:telehealth obesity monitoring
    n1=en:dermatologic disorder medication review | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=20
  244. administration de médicaments prescrits basée sur les résultats des gaz du sang artériel --- r_associated #0: 5 --> en:telehealth obesity monitoring
    n1=administration de médicaments prescrits basée sur les résultats des gaz du sang artériel | n2=en:telehealth obesity monitoring | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr